title: Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms syndrome induced by cilostazol and carbamazepine.
authors.forename: Sung-Yoon
authors.initials: SY
authors.lastname: Kang
authors.forename: Ju-Young
authors.initials: JY
authors.lastname: Kim
authors.forename: Mi-Yeong
authors.initials: MY
authors.lastname: Kim
authors.forename: Suh-Young
authors.initials: SY
authors.lastname: Lee
authors.forename: Min-Hye
authors.initials: MH
authors.lastname: Kim
authors.forename: Tae-Wan
authors.initials: TW
authors.lastname: Kim
authors.forename: Heung-Woo
authors.initials: HW
authors.lastname: Park
authors.forename: Sang-Heon
authors.initials: SH
authors.lastname: Cho
authors.forename: Kyung-Up
authors.initials: KU
authors.lastname: Min
mesh_terms: D002220:Carbamazepine / Q000009:adverse effects*; D000077407:Cilostazol; D003879:Dermatologic Agents / Q000627:therapeutic use; D004342:Drug Hypersensitivity / Q000188:drug therapy / Q000209:etiology / Q000473:pathology*; D004359:Drug Therapy, Combination; D004802:Eosinophilia / Q000188:drug therapy / Q000209:etiology / Q000473:pathology*; D006801:Humans; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D008875:Middle Aged; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage / Q000009:adverse effects*; D013577:Syndrome; D013777:Tetrazoles / Q000008:administration & dosage / Q000009:adverse effects*
chemical_list: D003879:Dermatologic Agents; D010975:Platelet Aggregation Inhibitors; D013777:Tetrazoles; D002220:Carbamazepine; D000077407:Cilostazol; D008775:Methylprednisolone